ClinicalTrials.gg
RecruitingNCT06430957Updated Mar 20, 2026

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

An observational study in Obstructive Sleep Apnea Risk Management, Postoperative Complications and Dental Caries Under General Anesthesia, sponsored by Kırıkkale University. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Kırıkkale University · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
240
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Obstructive sleep apnea (OSA) is a sleep-related respiratory dysfunction. The prevalence of OSA is increasing with the increasing rates of obesity and elderly population worldwide. Perioperative anesthesia management should be adjusted to improve patient safety in patients with OSA. In OSA patients, positive pressure ventilation support may be required in the preoperative period, various ventilation strategies may be required in the intraoperative period, different pharmacologic agents may need to be avoided, and intensive care unit follow-up or noninvasive ventilation support may be required in the postoperative period. However, it is reported that a significant percentage of OSA patients remain undiagnosed. ASA (American Society of Anesthesiologists) has reported the criteria that should be questioned in order to determine the risk of patients in terms of OSA and to initiate the diagnostic process in risky patients and to make appropriate anesthesiologic arrangements in the perioperative period. In addition, the STOP-BANG assessment scale, which is widely used all over the world in OSA risk assessment, is also used in OSA risk assessment. It is thought that dental caries and extraction needs may be higher in OSA patients, especially since open-mouth sleeping accompanies the situation. In this respect, it is also important for patients to be diagnosed with OSA as it may prevent dental damage due to open-mouth sleeping in the future. Identifying patients at risk for OSA and directing them to the diagnostic process is very important for patient safety. Within the scope of the study, the criteria recommended by ASA and STOP-BANG score will be evaluated and recorded. Risk stratification in terms of STOP-BANG questionnaire and ASA criteria will be done separately for each patient and for each classification method. Patients at high risk will be consulted to the relevant medical department in the preoperative period for further investigation and treatment. In addition, it is aimed to correlate the risk levels determined in the study with postoperative respiratory complications and recovery time.

02

Conditions studied

  • Obstructive Sleep Apnea Risk Management
  • Postoperative Complications
  • Dental Caries Under General Anesthesia
  • Obstructive Sleep Apnea of Adult
03

In context

Postoperative Complications

1,332 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.

This study's planned enrollment of 240 is close to the median of 251 across 537 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Kırıkkale University is the lead sponsor of 114 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients between the ages of 18-80 years who applied to the anesthesia clinic for dental procedures planned to be performed under general anesthesia and who had no previous diagnosis of OSA.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients between 18-80 years of age who apply to the anesthesia clinic for dental procedures planned to be performed under general anesthesia
  • Patients without a previous diagnosis of OSA

Exclusion criteria

Exclusion Criteria:

  • Individuals who do not want to participate in the study
  • Patients previously diagnosed with OSA
  • Necessity of emergency surgery
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
240 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group lowSTOP-B

    Study group including patients in the low-risk group in the assessment to be made with STOP-BANG questionnaire.

    Other: The STOP-BANG questionnaire for determining OSA risk level. · Other: Record of postoperative complications

  • Group intermediateSTOP-B

    Study group including patients in the medium-risk group in the assessment to be made with STOP-BANG questionnaire.

    Other: The STOP-BANG questionnaire for determining OSA risk level. · Other: Record of postoperative complications

  • Group highSTOP-B

    Study group including patients in the high-risk group in the assessment to be made with STOP-BANG questionnaire.

    Other: The STOP-BANG questionnaire for determining OSA risk level. · Other: Record of postoperative complications

  • Group noneASA

    The study group that includes patients who are not at risk for OSA in the evaluation with the criteria recommended by the ASA.

    Other: ASA recommended criteria for determining OSA risk level. · Other: Record of postoperative complications

  • Group mildASA

    Study group including patients in the mild-risk group for OSA in the evaluation with the criteria recommended by the ASA.

    Other: ASA recommended criteria for determining OSA risk level. · Other: Record of postoperative complications

  • Group moderateASA

    Study group including patients in the moderate-risk group for OSA in the evaluation with the criteria recommended by the ASA.

    Other: ASA recommended criteria for determining OSA risk level. · Other: Record of postoperative complications

  • Group severeASA

    Study group including patients in the severe-risk group for OSA in the evaluation with the criteria recommended by the ASA.

    Other: ASA recommended criteria for determining OSA risk level. · Other: Record of postoperative complications

Interventions

  • OtherThe STOP-BANG questionnaire for determining OSA risk level.

    An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.

  • OtherASA recommended criteria for determining OSA risk level.

    An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.

  • OtherRecord of postoperative complications

    Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.

06

What researchers measure

Primary outcomes

  1. Determination of OSA risk levels of patients

    The STOP-BANG questionnaire and the criteria recommended by the ASA, which are recommended to be used routinely worldwide to determine OSA risk level, will be questioned in each patient. Patients with moderate and high risk scores from the STOP-BANG questionnaire and patients with significant OSA risk level according to ASA criteria will be referred to the pulmonology department and further evaluation will be requested. If deemed necessary by the Pulmonology department, a sleep test will be performed. With the sleep test result, the OSA risk level of the patients will be classified as none, mild, moderate and severe in terms of ASA criteria.

    Time frame: Preoperative period

  2. Postoperative respiratory complications

    Respiratory complications including laryngospasm/bronchospasm, apnea, hypoxia that may develop in the postoperative period in patients, the duration of the need for additional oxygen support above the expected duration will be observed and recorded.

    Time frame: For 4 hours after the end of surgery

  3. Follow-up of indicators of airway obstruction

    As indicators of airway obstruction; snoring/whistling respiration, hypertension and intercostal/sternal retractions will be observed and recorded in the study follow-up form.

    Time frame: For 4 hours after the end of surgery

  4. Duration of recovery

    Duration of recovery (modified aldrete score of 9 and above) will be recorded

    Time frame: For 30 minutes after the end of surgery

Secondary outcomes

  1. Comparison of the effectiveness of STOP-BANG questionnaire and ASA criteria in determining OSA risk level

    Patients who will receive an intermediate or high risk score from either of the two assessment questionnaires will be referred for further evaluation and diagnosis of suspected OSA. At the end of the diagnostic process, it is planned to investigate which of the two scoring systems more successfully identifies patients with OSA and assigns a higher risk.

    Time frame: Perioperative period

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Aug 2026, 26 months after the start.

Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 26 months is above that.

Counting every sponsor, half of 281 studies reached it within 23 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
May 14, 2024
First posted
May 28, 2024
StartActual
Jun 28, 2024
Primary completionEst.
Aug 2026
CompletionEst.
Aug 2026
Last update
Mar 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06430957
Responsible party
Gözde Nur Erkan (Assistant Professor Doctor, Medical Doctor, Kırıkkale University) — Principal investigator
First posted
May 28, 2024
Start date
Jun 28, 2024
Primary completion
Aug 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Mar 20, 2026

Study contacts

Gözde Nur Erkan, Asst. Prof.
Contact
dr.gozdenur@gmail.com
+905054334692

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion